Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8329202rdf:typepubmed:Citationlld:pubmed
pubmed-article:8329202lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:8329202lifeskim:mentionsumls-concept:C0579233lld:lifeskim
pubmed-article:8329202lifeskim:mentionsumls-concept:C0225336lld:lifeskim
pubmed-article:8329202lifeskim:mentionsumls-concept:C1510802lld:lifeskim
pubmed-article:8329202lifeskim:mentionsumls-concept:C1533691lld:lifeskim
pubmed-article:8329202pubmed:issue5lld:pubmed
pubmed-article:8329202pubmed:dateCreated1993-8-19lld:pubmed
pubmed-article:8329202pubmed:abstractTextA model using human umbilical vein endothelial cells was developed to study the adhesion of group B streptococci. Ten clinical isolates of serotypes Ia, Ib and III, including six blood isolates from neonates with early-onset disease, were studied. Isogenic variants with different ability to express capsule substance were also included. Clinical isolates of serotype III adhered significantly better than other serotypes. Strains with high ability to adhere to endothelial cells also had high ability to bind to plastic. Isogenic variants of serotype III with low amounts of capsule substance adhered significantly better to cells than variants expressing high amounts of capsule substance. These results show that the higher adherence of serotype III strains may be a virulence factor and contribute to the finding that this serotype dominates in invasive group B streptococcal disease.lld:pubmed
pubmed-article:8329202pubmed:languageenglld:pubmed
pubmed-article:8329202pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8329202pubmed:citationSubsetIMlld:pubmed
pubmed-article:8329202pubmed:statusMEDLINElld:pubmed
pubmed-article:8329202pubmed:monthMaylld:pubmed
pubmed-article:8329202pubmed:issn0903-4641lld:pubmed
pubmed-article:8329202pubmed:authorpubmed-author:HåkanssonSSlld:pubmed
pubmed-article:8329202pubmed:authorpubmed-author:KihlströmEElld:pubmed
pubmed-article:8329202pubmed:authorpubmed-author:AnderssonAAlld:pubmed
pubmed-article:8329202pubmed:authorpubmed-author:SchollinJJlld:pubmed
pubmed-article:8329202pubmed:authorpubmed-author:KällmanJJlld:pubmed
pubmed-article:8329202pubmed:issnTypePrintlld:pubmed
pubmed-article:8329202pubmed:volume101lld:pubmed
pubmed-article:8329202pubmed:ownerNLMlld:pubmed
pubmed-article:8329202pubmed:authorsCompleteYlld:pubmed
pubmed-article:8329202pubmed:pagination403-8lld:pubmed
pubmed-article:8329202pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:8329202pubmed:meshHeadingpubmed-meshheading:8329202-...lld:pubmed
pubmed-article:8329202pubmed:meshHeadingpubmed-meshheading:8329202-...lld:pubmed
pubmed-article:8329202pubmed:meshHeadingpubmed-meshheading:8329202-...lld:pubmed
pubmed-article:8329202pubmed:meshHeadingpubmed-meshheading:8329202-...lld:pubmed
pubmed-article:8329202pubmed:meshHeadingpubmed-meshheading:8329202-...lld:pubmed
pubmed-article:8329202pubmed:meshHeadingpubmed-meshheading:8329202-...lld:pubmed
pubmed-article:8329202pubmed:meshHeadingpubmed-meshheading:8329202-...lld:pubmed
pubmed-article:8329202pubmed:meshHeadingpubmed-meshheading:8329202-...lld:pubmed
pubmed-article:8329202pubmed:meshHeadingpubmed-meshheading:8329202-...lld:pubmed
pubmed-article:8329202pubmed:year1993lld:pubmed
pubmed-article:8329202pubmed:articleTitleAdherence of group B streptococci to human endothelial cells in vitro.lld:pubmed
pubmed-article:8329202pubmed:affiliationDepartment of Infectious Diseases, Medical Center Hospital, Orebro, Sweden.lld:pubmed
pubmed-article:8329202pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8329202pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8329202lld:pubmed